Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
Q2 2026 vs. Q1 2026
How the institutions holding Matinas BioPharma Holdings, Inc. changed between Q1 2026 and Q2 2026.
All holders in Q2 2026All holders in Q1 2026
| Measure | Q1 2026 | Q2 2026 | Change |
|---|---|---|---|
| Holders | 28 | 25 | −3 |
| Shares | 354.4K | 325.1K | −29.3K (−8.3%) |
| Value | $177.3K | $199.2K | +$22.0K (+12.4%) |
New holders (2)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q2 2026 but not at the end of Q1 2026.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Northwestern Mutual Wealth Management Co | 20 | $12 | 0.00% |
| IFG Advisory, LLC | 10 | $6 | 0.00% |
Sold out (5)
Institutions that held Matinas BioPharma Holdings, Inc. at the end of Q1 2026 and filed for Q2 2026 without it.
| Institution | Shares, Q1 2026 | Value, Q1 2026 |
|---|---|---|
| XTX Topco Ltd | 20,706 | $10.4K |
| UBS Group AG | 184 | $92 |
| Steward Partners Investment Advisory, LLC | 61 | $31 |
| FMR LLC | 7 | $4 |
| MAI Capital Management | 2 | $1 |